Navigation Links
Avitar's Notes Significance of New On-Site Oral Fluid Drug Testing Laws
Date:8/19/2007

Drug Free Workplace Programs To Become More Effective, Widespread

CANTON, Mass., Aug. 15 /PRNewswire-FirstCall/ -- Avitar, Inc. (OTC Bulletin Board: AVTI) highlights the importance of the State of Hawaii's recent updating of their workplace drug testing laws to incorporate oral fluid-based on-site technology and its associated benefits.

"The State of Hawaii's new law enabling on-site oral fluid-based drug testing dramatically improves any company's ability to promote a drug free workplace and truly manage on-the-job drug abuse," said Pete Phildius, Chairman & CEO of Avitar. "Most employers know that workplace drug abuse is as bad if not worse than ever," continued Phildius. "The convenience of on- site oral fluid testing, when compared to traditional laboratory-based urine drug testing, will play an important role in reversing this costly trend."

In response to the support of multiple trade unions and industries, Hawaii enacted a new law which went into effect July 1, 2007, allowing companies that previously used laboratory-based urinalysis to use newer on-site oral fluid- based technology.

"Drug and alcohol abuse remain a problem in Hawaii's workforce. The law will go a long way towards helping to promote a drug-free workplace. This measure provides a cost effective on-the-job alternative to lab tests that can be costly and difficult to schedule." -- Lt. Governor Aiona.

The construction industry in particular advocated the need to replace urine-based testing, noting that on-site oral fluid devices are cheaper, faster and easier to use than urinalysis. Traditional urine testing typically takes several days to obtain results, and requires applicants or employees to go to specified collections sites/clinics. On-site oral fluid technology provides initial results within 5-15 minutes at a fraction of the cost of urine lab tests. Any non-negative on-site test results can also be confirmed in a laboratory using oral fluid. Lastly, or
'/>"/>

SOURCE Avitar, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related biology technology :

1. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
2. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
3. General Notes on Primer Design in PCR*
4. Musicnotes reports 45 percent growth in 2006
5. Musicnotes strikes deal to distribute Sony/ATV sheet music
6. Musicnotes signs licensing deal with Christian music provider
7. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
8. Esker Fax Engine Provides High-Performance, High-Value Fax to The Lotus Notes(R) Enterprise
9. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
10. Maximize Viral RNA Yield from Biological Fluid
11. Genomic DNA Isolation From 1 ml of Body Fluid

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Newswire-FirstCall/ -- BioSpecifics Technologies C... developing first-in-class collagenase-based produ... third quarter ended September 30, 2009. ,, "W...year, the FDA,s Arthritis Advisory Committee unani...l of XIAFLEX(TM) for the treatment of Dupuytren,s ...
(Date:11/5/2009)... Wound Management Technol...ntered into a Letter of Intent to purchase all hea...ies, Inc. (OTC Bulletin Board: VHGI). The deal pro...ebt, 4,000,000 shares of WNDM and a royalty agreem...p technology being acquired from VHGI. WNDM clos...
(Date:11/5/2009)...RNewswire-FirstCall/ -- WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today ... the company,s Scientific Advisory Board. His car...ing novel molecular diagnostics for cancer detecti...of computational biology systems for several biote...
(Date:11/5/2009)... Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunston...the "Company") today announced,that the Company pl...s on,Monday, November 9, 2009, after the market cl...e call at 5:00 pm ET on November 9, 2009,to discus...s the call by,dialing 1-888-713-4211 or 1-617-213-...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
... EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS... treatment of multiple sclerosis (MS), announced,t...bid. Under the bid,which will be conducted pursuan..."), the Company may purchase up to 1,000,000 of it...esenting approximately 1.1% of the,Company,s issue...
.... (Nasdaq:,PLXS) announced today that it intends t...tered into an agreement to lease approximately 106...ted in Hangzhou. The new,facility will allow Plexu...ecision centers in the greater Shanghai area, and ...tal cost value proposition. This location,will be ...
...ity of Manchester who discovered the world,s thinn...work. , Professor Andre Geim FRS and Dr Kostya No...ology have been awarded the prestigious Europhysic...ubsequent work to reveal its remarkable electronic... of carbon atoms resembling chicken wire. This inc...
Other Biology Technology:BioMS Medical announces its intention to renew a normal course issuer bid 2BioMS Medical announces its intention to renew a normal course issuer bid 3Plexus Announces Expansion in Hangzhou, China 2Plexus Announces Expansion in Hangzhou, China 3Graphene pioneers follow in Nobel footsteps 2
(Date:11/3/2009)...en are as much as 28 percent less likely to become...ng to research that earned a Michigan State Univer...by Barbara Luke, a researcher in the MSU College o...ology and Reproductive Biology, focused on data of...echnology. , Luke,s findings, which also can be ...
(Date:11/3/2009)...y Samueli School of Engineering and Applied Scienc...ed in the laboratory the enzyme responsible for pr...lovastatin. , The research, published Oct. 23...to the development of other compounds with similar...esizing enzyme is one of the most interesting but ...
(Date:11/3/2009)...of Illinois at Chicago have received $1 million fr... study the relationship between "fat taxes" and fo...funding for the two-year project was made availabl...ct of 2009. , The study will link state tax rate...gar- and fat-laden foods and beverages (soda, cand...
Breaking Biology News(10 mins):MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 1Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 3Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 4Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 5Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 6Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 7Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 8Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 9Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 10Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 11Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 12Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 1Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 2Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 3Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 1Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 2
...e about how the brain assigns cells to participate...versity of Toronto team has discovered that a prot...ing a role in memory formation. The April 20 edit... a new approach for preserving memory in people su... , "Making a memory is not a conscious act," expla...
...al nervous system (CNS) in animal evolution has pu...ts and worms evolved from the same ancestor, but t...volved only after their lineages had split during ... Biology Laboratory (EMBL) in Heidelberg now revea...uch older than expected. The study, which is publi...
...tel, cancer is a metaphorical example of the perfe...regnant finch that landed on a deserted island in ...n the human body has to undergo many mutations thr...vader of different organs in the body. But once it...fferent ecological niches, cancer is tough to get ...
Other Biology News:UCLA/Toronto researchers unlock key to memory storage in brain 2The origin of the brain lies in a worm 2New bird, bat species revealed by extensive DNA barcode studies 2
Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience
Weinreb Linker from ChemPep, Inc.
Biology Products: